Pharmacist's Letter Canada

Article: Xeljanz (ZEL-jans, tofacitinib), a new ORAL treatment for moderate to severe rheumatoid arthritis in adults September 2014

Commentary: DMARDs in the Treatment of Rheumatoid Arthritis September 2014

Article: More ORAL antibiotics will be used for bone or joint infections August 2014

Chart: Antimicrobial Drug Interactions and Warfarin August 2014

Guideline: Diagnosis and Management of Prosthetic Joint Infection: Clinical Practice Guidelines by the Infectious Diseases Society of America (2012) August 2014

PL Voices: Oral Antibiotics for Bone or Joint Infections August 2014

Patient Education: What I Need to Know About Benzodiazepines July 2014

Chart: Comparison of Atypical Antipsychotics May 2014

Article: Abilify Maintena (aripiprazole) will be another intramuscular long-acting atypical antipsychotic option May 2014

Commentary: Digoxin for Atrial Fibrillation April 2014

Article: You'll get questions about appropriate use and dosing of digoxin April 2014

Article: green tea may interfere with some meds March 2014

Commentary: OATP Drug Interactions March 2014

Article: fewer red flags when celecoxib (Celebrex) is given to patients with a sulfa allergy February 2014

Commentary: Calcium Channel Blocker-Macrolide Interaction January 2014